Market Overview
10 Target Markets
Our technology platform can be broken down into 10 broad categories. This Market Overview is not intended to be a precise forecasting tool, rather it merely provides a broad overview of the markets targeted. The company that advances this technology will create new markets and disrupt existing ones. What percentage of each market that can be captured with low frequency ultrasound technology is difficult to ascertain with precision.
- Wound Care ($20.59 billion)
- Orthopedic ($3.7 billion)
- Infection Control ($201.4 billion)
- Pain Management ($6.4 billion)
- Vaccine Development ($138.7 billion)
- Water ($207.7 billion)
- Fuel ($887.19 billion)
- Cardiovascular ($8 billion)
- Oncology ($265.1 billion)
- Anti aging ($58.5 billion)
Target Markets
Wound Care
Infection Control
Wound Care
The global wound care market size was valued at USD 20.59 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 4.12% from 2022 to 2030. The demand for wound care products is increasing owing to increasing number of surgical cases, and rising prevalence of chronic diseases across the globe. Furthermore, increasing incidence of diabetes due to sedentary lifestyle is one of the leading factors contributing to market growth. For instance, according to American Diabetes Association, in 2018, an estimated 34.2 million people, i.e., 10.5% of the total U.S. population, had diabetes. Moreover, nearly 1.6 million U.S. residents had type 1 diabetes, which includes about 187,000 adolescents and children. Learn More
You can access our wound care technology here
Orthopedic
Infection Control
Wound Care
Global Ultrasonic Scalpels Market to Reach $3.7 Billion by 2026. The global market for Ultrasonic Scalpels estimated at US$2.5 Billion in the year 2020, is projected to reach a revised size of US$3.7 Billion by 2026, growing at a CAGR of 6.3% over the analysis period. General Surgery, one of the segments analyzed in the report, is projected to grow at a 7.1% CAGR to reach US$1.4 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Urology & Gynecology segment is readjusted to a revised 6.4% CAGR for the next 7-year period. Learn More
You can access our orthopedic technology here
Infection Control
Infection Control
Infection Control
The global infection control market size was estimated at USD 201.4 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.7% from 2022 to 2030. The market is predominantly driven by growing number of surgical procedures that require high-intensity infection prevention. The high preference is presumed to be a consequence of positive clinical outcomes associated with usage of infection control. The covid-19 pandemic has positively impacted market growth as the demand for sterilization and disinfection in hospitals and clinics, pharmaceutical, and medical device companies has increased. Learn More
You can access our infection control technology here
Pain Management
Vaccine Development
Infection Control
The global pain management devices market size was valued at USD 6.40 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 9.3% from 2022 to 2030. The increasing prevalence of chronic diseases is one of the key factors expected to contribute to the market growth over the forecast period. The growing prevalence of lifestyle disorders, such as obesity and diabetes, has increased the demand for muscle and nerve stimulators. The growing prevalence of trauma or hypertension is another major factor likely to drive the market growth. Hypertension significantly increases the risk of a brain aneurysm and other chronic diseases. Learn More
You can access our pain management technology here.
Vaccine Development
Vaccine Development
Vaccine Development
Vaccines Market size exceeded USD 138.7 billion in 2021 and will grow momentously at 5.6% CAGR during the forecast period. Increasing prevalence of viral infectious diseases are one of the major threats affecting large population across the globe. The higher incidence rate of hepatitis and human papilloma virus that can lead to severe health conditions in case of improper diagnosis will drive the demand for preventive vaccination, thereby stimulating the global market growth. Learn More
You can access our vaccine technology here.
Water Treatment
Vaccine Development
Vaccine Development
Potable drinking water. The global bottled water market size was valued at US$ 207.7 billion in 2020. Bottled water is meant for human consumption and sealed in food grade bottles. The rising awareness regarding the ill effects of drinking contaminated water is driving the growth of the global bottled water market across the globe. The growing penetration of food service industry, rising penetration of organized retail sector, and demand for healthy and active lifestyle is significantly propelling the growth of the global bottled water market. The rising urban population, increasing personal disposable income, improved living standards, and the development of eco-friendly materials for bottles are the several crucial factors accountable for the growth of the bottled water market globally. The rising government initiatives to promote the adoption of eco-friendly and sustainable packaging is expected to drive the demand for the bio-degradable bottled water. Learn More
You can access our water technology here
Target Markets (cont.)
Clean Fuel
Cardiovascular
Cardiovascular
The global renewable fuel market size was accounted at US$ 887.19 billion in 2021. Technological developments and the adoption of novel technologies are two significant drivers propelling the global renewable fuel market forward. The increase in electricity consumption is also strengthening the worldwide renewable fuel sector. Furthermore, increased government measures to boost the power industry are adding to the worldwide renewable fuel market's growth. The government offers subsidies and incentives to market participants in the worldwide renewable energy industry. The leading market players are putting an even greater emphasis on long-term value, and several of the region's largest market participants have developed sustainable sourcing methodologies for evaluating long-term contracts. Learn More
You can access our fuel technology here.
Cardiovascular
Cardiovascular
Cardiovascular
Drug-Eluting Stents Market Size to Hit $8.77 Billion by 2027: Increase in prevalence of cardiovascular disease, advent of advanced drug-eluting stents, and rise in demand for minimally invasive surgical procedures drive the growth of the global drug-eluting stents market. The market across North America held the largest share in 2019, accounting for nearly two-fifths of the market. Manufacturing and distributing companies of drug-eluting stents have severely affected by Covid-19 and the rise in the number of Covid-19 patients is resulted in short supply. Learn More
Renal denervation. The global renal denervation market size was estimated at USD 41.7 million in 2017 and is anticipated to expand at a CAGR of 43.2% over the forecast period. Factors, such as growing cases of therapy-resistant hypertension is one of the key growth-driving factors for the market. Hypertension is one of the most common diseases in the world. As per the Centers for Disease Control and Prevention (CDC), in 2013, more than 360,000 people in America died due to high blood pressure. The occurrence of hypertension has increased from 17,307 per 100,000 in 1990 to 20,525 per 100,000 in 2015. However, renal denervation therapy has shown a positive result in reducing hypertension. Thus, the advantages offered by these therapies, such as permanent effect, reduced treatment time, and higher safety, are boosting the market growth. Furthermore, the advancement of renal denervation devices is likely to drive the market. Learn More
You can access our cardiovascular technology here.
Oncology
Anti-aging
Anti-aging
The global oncology market size was reached at US$ 265.1 billion in 2020. The global oncology market is driven by the rising prevalence of cancer disease among the global population that significantly fosters the demand for the various oncology diagnostics and treatment products. Around 10 million cancer deaths were recorded in 2020 and around 19.3 million new cancer cases were diagnosed globally in 2020, as per the data provided by the International Agency for Research on Cancer in its report named GLOBOCAN. The rising awareness regarding cancer and availability of various oncology treatment and innovative diagnostic tools for detecting cancer. The rising investments by the biopharmaceutical industry players in the research and clinical trials of various therapeutics and diagnostics are expected to fuel the growth of the global oncology market during the forecast period. Learn More
You can access our oncology technology here.
Anti-aging
Anti-aging
Anti-aging
The global anti-aging market reached a value of US$ 58.5 Billion in 2020. Looking forward, the market is expected to reach a value of US$ 88.30 Billion by 2026, exhibiting a CAGR of 7.10% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor. The growing consciousness among both the young and old consumers regarding their physical appearance has fostered the demand for anti-aging products and devices. Learn More
You can access our anti-aging technology here.